Stryker Corporation (SYK) Position Held by Segment Wealth Management LLC

Segment Wealth Management LLC held its stake in Stryker Corporation (NYSE:SYK) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,790 shares of the medical technology company’s stock at the end of the second quarter. Segment Wealth Management LLC’s holdings in Stryker Corporation were worth $248,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Bollard Group LLC boosted its position in Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares during the period. Assetmark Inc. lifted its holdings in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares in the last quarter. Blue Chip Partners Inc. lifted its holdings in shares of Stryker Corporation by 0.3% in the first quarter. Blue Chip Partners Inc. now owns 1,775 shares of the medical technology company’s stock worth $234,000 after buying an additional 6 shares in the last quarter. Guardian Life Insurance Co. of America lifted its holdings in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after buying an additional 9 shares in the last quarter. Finally, FineMark National Bank & Trust lifted its holdings in shares of Stryker Corporation by 0.4% in the second quarter. FineMark National Bank & Trust now owns 3,878 shares of the medical technology company’s stock worth $538,000 after buying an additional 15 shares in the last quarter. Hedge funds and other institutional investors own 74.13% of the company’s stock.

Stryker Corporation (NYSE SYK) opened at 146.41 on Thursday. Stryker Corporation has a one year low of $106.48 and a one year high of $149.23. The stock has a 50 day moving average of $142.50 and a 200 day moving average of $140.33. The company has a market cap of $54.77 billion, a PE ratio of 32.68 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. During the same quarter in the prior year, the firm posted $1.39 EPS. Stryker Corporation’s quarterly revenue was up 6.1% compared to the same quarter last year. On average, analysts anticipate that Stryker Corporation will post $6.45 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.16%. Stryker Corporation’s payout ratio is presently 37.95%.

TRADEMARK VIOLATION NOTICE: This story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://sportsperspectives.com/2017/10/12/stryker-corporation-syk-position-held-by-segment-wealth-management-llc.html.

In other Stryker Corporation news, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the transaction, the insider now owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Corporate insiders own 7.40% of the company’s stock.

A number of equities research analysts have recently issued reports on the stock. SunTrust Banks, Inc. reissued a “buy” rating and issued a $161.00 price target on shares of Stryker Corporation in a report on Monday, October 2nd. Stifel Nicolaus increased their price target on shares of Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, July 28th. BidaskClub downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Canaccord Genuity reissued a “buy” rating and issued a $155.00 price target (down from $158.00) on shares of Stryker Corporation in a report on Thursday, August 24th. Finally, Argus reissued a “buy” rating and issued a $160.00 price target on shares of Stryker Corporation in a report on Tuesday, August 29th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $146.78.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply